HACD3 promotes malignant progression of NSCLC by suppressing the MKK7/MAPK10 signaling axis. - Wang, Xiaoying; Liang, Huijun; Du, Qindan; Li, Ying; Zhao, Yong (BMC Cancer, 2025)